The survey results come from experts warning that a current lack of vaccine trust could be enough to undermine the effectiveness of ending the pandemic.
Almost 60 percent of Croatians do not plan to take a vaccine against the coronavirus once it becomes available. This was the result of a recent survey.
According to the survey carried out last week by market research company Valicon and published by the Croatian news agency RTL, 43 percent of respondents said they would definitely or probably vaccinate, citing mainly responsibility to others and a higher vaccination rate than infections Curb reasons.
But 57 percent said they would definitely not or probably not vaccinate, citing suspicion of the vaccine until it was found to be safe, while large numbers of respondents also feared that there might be side effects.
Others said they would not vaccinate because they believed they were not at risk, while a quarter of respondents said the virus was constantly mutating and vaccination would not protect them.
The poll, which gathered opinions from 523 people in Croatia, is a global scientific race to create an effective vaccine against the coronavirus.
Last week, US drug maker Pfizer and its German partner BioNTech released final data from late-stage studies showing their vaccine was 95 percent effective, its highest rate of effectiveness yet.
Vaccination trust affects effectiveness
The results of the Croatian survey reflect a broader global trend.
Reluctance to get a coronavirus vaccine seems to be growing, according to a World Economic Forum (WEF) report earlier this month in which fewer people said they were taking a COVID-19 vaccine than they were three months ago.
The Ipsos Vaccine Trust Survey shows that vaccine intent has decreased by an average of four percentage points in 15 countries since August.
The survey shows that 73 percent of adults strongly or somewhat disagreed that “if a vaccine for COVID-19 were available I would get it”. Three months ago the number was 77 percent.
Intention to vaccinate has decreased in 10 countries – especially in China, Australia, Spain and Brazil.
However, more than four in five in India, mainland China, South Korea and Brazil say they would receive a vaccine if available – compared to just over half in France and about two-thirds in the US, Spain, Italy and South Africa. Japan and Germany.
Meanwhile, 34 percent of those worldwide who would not want to receive a vaccine said they were concerned about side effects, while another 33 percent said clinical trials are moving too quickly.
Experts estimate that at least 70 percent of the population must be immune to the coronavirus to stop the spread of a disease in the community that has killed nearly 1.4 million people worldwide.
To do that, public confidence in a vaccine needs to be particularly high, and the current shortage may be enough to limit its effectiveness, the WEF said.